stay updated with our newsletter

Anticholinergic Drugs May Accelerate Cognitive Decline

anticholinergic drugs

A team of scientists, led by researchers at University of California San Diego School of Medicine, report that anticholinergic drugs used for a broad array of conditions, from allergies and colds to hypertension and urinary incontinence, may be associated with an increased risk of cognitive decline, particularly in older adultsRead

Integrative Medicine Research Journal: Special COVID-19 Issue

The Sept. 2020 special edition of the Integrative Medicine Research Journal is dedicated exclusively to COVID-19 research. For your ease of use, we’ve compiled all the articles here in a list. Please click through to each article, all are open access. Editors Drs. Myeong SooLee, Eunhye Song write: “Given theseRead

It’s Not Kawasaki … It’s PIMS-TS in Children with COVID-19

children with COVID-19

Researchers have uncovered how the immune system is altered in a rare coronavirus related illness in children with COVID-19 referred to as pediatric inflammatory multisystem syndrome (PIMS-TS). PIMS-TS is a rare syndrome which has emerged in a small number of children during the COVID-19 pandemic. The condition causes severe inflammationRead

Menopause Society Endorses Multifaceted DHEA Therapy

menopause

The North American Menopause Society (NAMS) announces publication of its 2020 Genitourinary Syndrome of Menopause (GSM) Position Statement. The new recommendations reflect the healthcare community’s most recent and proven safe and effective therapies for treating women with GSM, including intravaginal dehydroepiandrosterone (DHEA), oral ospemifene, and a low-dose estradiol vaginal insert.Read

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.